Scarica l'app Stockscreener
49.68
0.24%
0.12
Dopo l'orario di chiusura:
53.61
3.93
+7.91%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVMD Giù?
Forum
Previsione
Precedente Chiudi:
$49.56
Aprire:
$50
Volume 24 ore:
1.75M
Relative Volume:
0.91
Capitalizzazione di mercato:
$9.29B
Reddito:
$29.52M
Utile/perdita netta:
$-567.06M
Rapporto P/E:
-13.57
EPS:
-3.66
Flusso di cassa netto:
$-551.11M
1 W Prestazione:
+4.34%
1M Prestazione:
+11.14%
6M Prestazione:
+37.24%
1 anno Prestazione:
-1.47%
Intervallo 1D:
$49.05
$51.70
Intervallo di 1 settimana:
$47.28
$51.70
Portata 52W:
$29.17
$62.40
Revolution Medicines Inc Stock (RVMD) Company Profile
Nome
Revolution Medicines Inc
Settore
Industria
Telefono
415-766-3638
Indirizzo
700 SAGINAW DR, REDWOOD CITY, CA
Confronta RVMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
49.68 | 8.88B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-12 | Ripresa | Raymond James | Strong Buy |
| 2025-09-05 | Iniziato | Truist | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-08-15 | Iniziato | Wells Fargo | Overweight |
| 2025-07-15 | Iniziato | Goldman | Buy |
| 2024-07-16 | Reiterato | Needham | Buy |
| 2024-07-12 | Iniziato | Barclays | Overweight |
| 2024-07-08 | Iniziato | Jefferies | Buy |
| 2024-04-12 | Reiterato | Needham | Buy |
| 2024-04-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | Iniziato | Piper Sandler | Overweight |
| 2024-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-04 | Iniziato | Wedbush | Outperform |
| 2023-11-16 | Iniziato | Raymond James | Outperform |
| 2023-02-28 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-10-21 | Iniziato | Oppenheimer | Outperform |
| 2022-05-20 | Iniziato | BofA Securities | Neutral |
| 2022-03-01 | Aggiornamento | Stifel | Hold → Buy |
| 2021-09-23 | Iniziato | Stifel | Hold |
| 2021-08-12 | Downgrade | Goldman | Buy → Neutral |
| 2021-05-18 | Iniziato | Goldman | Buy |
| 2020-05-21 | Iniziato | H.C. Wainwright | Buy |
| 2020-03-09 | Iniziato | Cowen | Outperform |
| 2020-03-09 | Iniziato | Guggenheim | Buy |
| 2020-03-09 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Revolution Medicines Inc Borsa (RVMD) Ultime notizie
Revolution Medicines Receives FDA Voucher for Daraxonrasib Under National Priority Voucher Pilot Program - Quiver Quantitative
Revolution Medicines Awarded CNPV Voucher for Daraxonrasib | RVMD Stock News - Stock Titan
Revolution Medicines Awarded Voucher for Daraxonrasib - GlobeNewswire
US FDA announces recipients of national priority vouchers - Reuters
How Revolution Medicines Inc. stock performs in rising dollar environmentQuarterly Portfolio Review & High Return Trade Guides - newser.com
Revolution Medicines (RVMD) Receives New 'Buy' Rating from Stife - GuruFocus
Revolution Medicines (RVMD) Positioned for Growth with Promising Market Potential - GuruFocus
Using data filters to optimize entry into Revolution Medicines Inc. Equity Warrant2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Is a relief rally coming for Revolution Medicines Inc. holders2025 Market Trends & Weekly Market Pulse Updates - newser.com
Will Revolution Medicines Inc. outperform the market2025 Biggest Moves & Weekly Watchlist for Hot Stocks - newser.com
How sentiment analysis helps forecast Revolution Medicines Inc. Equity Warrant - newser.com
Measuring Revolution Medicines Inc. Equity Warrant’s beta against major indicesJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
What earnings revisions data tells us about Revolution Medicines Inc.Forecast Cut & Smart Money Movement Alerts - newser.com
How high can Revolution Medicines Inc. Equity Warrant stock go2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Full technical analysis of Revolution Medicines Inc. Equity Warrant stock - newser.com
Is now a turning point for Revolution Medicines Inc. Equity WarrantJobs Report & Technical Pattern Based Buy Signals - newser.com
Is Revolution Medicines Inc. stock a bargain at current levelsTrend Reversal & Trade Opportunity Analysis - newser.com
Is Revolution Medicines Inc. Equity Warrant forming a reversal patternJuly 2025 WrapUp & Low Volatility Stock Suggestions - newser.com
How analysts rate Revolution Medicines Inc. stock todayMarket Growth Review & Low Risk High Reward Ideas - newser.com
Revolution Medicines (RVMD) Stock Analysis: Unveiling a 56% Potential Upside Amidst Robust Buy Ratings - DirectorsTalk Interviews
Using data models to predict Revolution Medicines Inc. stock movementJuly 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
What recovery options are there for Revolution Medicines Inc.2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Can technical indicators confirm Revolution Medicines Inc.’s reversalTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Why Revolution Medicines Inc. Equity Warrant stock appeals to dividend seekersOptions Play & Long-Term Capital Growth Ideas - newser.com
Should you wait for a breakout in Revolution Medicines Inc. Equity WarrantGap Up & Community Shared Stock Ideas - newser.com
How Revolution Medicines Inc. stock performs in interest rate cycles2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Revolution Medicines Inc. Equity Warrant stock volume spike explained2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Revolution Medicines (NASDAQ:RVMD) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
How analysts revise price targets for Revolution Medicines Inc. (42Z) stockJuly 2025 Market Mood & Community Consensus Stock Picks - newser.com
What recovery options are there for Revolution Medicines Inc. Equity WarrantQuarterly Portfolio Summary & Low Volatility Stock Recommendations - newser.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition - Investing.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition By Investing.com - Investing.com South Africa
Revolution Medicines Inc Azioni (RVMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Revolution Medicines Inc Azioni (RVMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kelsey Stephen Michael | See Remarks |
Oct 13 '25 |
Sale |
48.54 |
25,000 |
1,213,540 |
284,047 |
| Cislini Jeff | General Counsel |
Sep 24 '25 |
Sale |
44.26 |
1,799 |
79,624 |
50,425 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):